LUCY
Innovative Eyewear Inc.
NASDAQ: LUCY · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$1.05
+0.96% today
Updated 2026-04-30
Market cap
$6.49M
P/E ratio
—
P/S ratio
2.44x
EPS (TTM)
$-1.90
Dividend yield
—
52W range
$1 – $5
Volume
0.1M
Innovative Eyewear Inc. (LUCY) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-40263.00 | $-40263.00 | $-1.21M | $-3.22M | $-5.77M | $-6.74M | $-7.28M |
| Capital expenditures | $20782.00 | $59039.00 | $118454.00 | $219951.00 | $251498.00 | $266973.00 | $72509.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $0.00 | $81645.00 | $1.33M | $1.47M | $936769.00 | $774788.00 | $738170.00 |
| Free cash flow | $-61045.00 | $-99302.00 | $-1.33M | $-3.44M | $-6.02M | $-7.01M | $-7.35M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |